Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Vitiligo and alopecia areata might be early signs of Type 1 Diabetes.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Alopecia areata causes hair loss and needs personalized care to manage its emotional and social effects.

Early intervention and patient education are crucial for managing alopecia areata.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Protecting hair and scalp from sunlight may help prevent hair loss.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

AGA linked to inflammation, stress, fibrosis, and disturbed hair follicle stem cells.

Common gene patterns may cause skin autoimmune diseases.